Skip Navigation
Search Menu
Find an Expert

 


Benjamin Philip Levy, M.D.

Photo of Dr. Benjamin Philip Levy, M.D.

Clinical Director of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital

Assistant Professor of Oncology

Male

Expertise: Head and Neck Cancers, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Thoracic Cancer, Thymic Carcinoma ...read more

Locations

Sidney Kimmel Cancer Center at SMH

5255 Loughboro Rd NW
First Fl Bldg B
Washington, DC 20016 map
Phone: 202-660-6500
Fax: 202-660-6501

Background

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology for Johns Hopkins University School of Medicine. Dr. Levy is board certified in medical oncology and hematology by the American Board of Internal Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.

Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer.

Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City.

Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee.

...read more

Titles

  • Clinical Director of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital
  • Assistant Professor of Oncology

Departments / Divisions

Education

Degrees

  • MD, Augusta University (2002)

Residencies

  • MedStar Georgetown University Medical Center / Internal Medicine (2005)

Fellowships

  • New York Presbyterian Hospital - Cornell Campus / Hematology and Oncology (2009)

Board Certifications

  • American Board of Internal Medicine / Hematology (2010)
  • American Board of Internal Medicine / Medical Oncology (2009)

Research & Publications

Research Summary

Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents.

Selected Publications

View all on Pubmed

Becker DJ, Wisnivesky JP, Grossbard ML, Chachoua A, Camidge DR, Levy BP. "Survival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor Therapy." Clin Lung Cancer. 2017 Jan;18(1):e35-e40. doi: 10.1016/j.cllc.2016.08.008.

Levy BP, Rao P, Becker DJ, Becker K. "Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated With Tyrosine Kinase Inhibitors." Oncology (Williston Park). 2016 Jul;30(7):601-12. Review.

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. "Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations." Oncologist. 2015 Oct;20(10):1175-81. doi: 10.1634/theoncologist.2015-0114.

Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. "Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial." Lancet Oncol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9.

Levy BP, Becker DJ. "The time for low-dose computed tomography screening is now: a medical oncologist perspective." Oncology (Williston Park). 2014 Nov;28(11):964-6. No abstract available.

Activities & Honors

Memberships

  • American Society of Clinical Oncology (ASCO)

    Associate Editor, ASCO University Committee

    {line break}

    ASCO Leadership Development Program

  • Alliance for Clinical Trials in Oncology

    Respiratory Committee

  • International Association for the Study of Lung Cancer

    Staging Committee

    {line break}

    Career Development & Fellowship Committee

Professional Activities

  • Ad Hoc Reviewer, Clinical Lung Cancer
  • Ad Hoc Reviewer, The Oncologist
  • Ad Hoc Reviewer, Oncotarget

Videos & Media

Recent News Articles and Media Coverage

Liquid Biopsies in Lung Cancer. Cancer Network (12/08/2016)

Prominent Oncologist Named Co-Chair for 34th Annual Chemotherapy Foundation Symposium. PR Web (03/30/2016)

Young Lung Cancer Patients: Prime for targeted therapies. Medscape (09/09/2015)

Washington Heights Man’s Lung Cancer Diagnosis Has Genetic Properties That Helped Fight Medical Battle. New York Daily News (08/01/2015)

Decision Time for Lung Cancer Screening in High-Risk Populations. The ASCO Post (04/15/2014)

Next Generation Sequencing in Lung Cancer. Oncology Tube (07/07/2013)

Johns Hopkins Kimmel Cancer Center Names Benjamin Levy to Lead Medical Oncology Program at Sibley Memorial Hospital

 

Is this you? Edit Profile